Is a complete ALT research report available?

No complete published report is available for Altimmune, Inc. (ALT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Altimmune, Inc. (ALT)

NASDAQ: ALT · USD

$2.77

-0.07 (-2.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ALT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	538.7M
Revenue (ttm)	36K
Net income (ttm)	-91.1M
EPS (ttm)	-$0.91
Shares out	194.5M
Volume	1,911,556
Beta	0.24
Price target	$16.9	+509.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36K
Net income (ttm): -91.1M
EPS (ttm): -$0.91
Market cap: 538.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ALT indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001326190
Company name	Altimmune, Inc.
Country	United States
Country code	US
Cusip	02155H200
Employees	57
Employees Change	-2%
Employees Change Percent	-3.39
Enterprise value	$243M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US02155H2004
Last refreshed	2026-07-26
Market cap	$538.7M
Market cap category	Small-Cap
Price	$2.77
Price currency	USD
Rev Per Employee	631.58x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	ALT
Website	https://altimmune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.91%
EV/Sales	6,750.01x
FCF yield	-13.3%
P/B ratio	1.27x
P/S ratio	14,963.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-269,216.67%
EBITDA Margin	-268,922.22%
Gross Profit	$-66.1M
Net Income	$-91.1M
Net Income Growth Years	1%
Pretax Margin	-253,002.78%
Profit Per Employee	$-1.6M
ROA	-24.4
Roa5y	-27.72
ROCE	-29.88
ROE	-42.75
Roe5y	-49.36
ROIC	-25.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.45%
Cagr3y	-4.09%
Cagr5y	-20.79%
EPS Growth Quarters	7
EPS Growth Years	4
Revenue Growth	80x
Revenue Growth Years	1x
Revenue Growth5 Y	-64.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$335.6M
Cash	$331.5M
Current Assets	$334.7M
Current Liabilities	$11.3M
Debt	$35.8M
Debt Equity	$0.13
Equity	$284M
Interest Coverage	-35.86
Liabilities	$51.6M
Long Term Assets	$954,000
Long Term Liabilities	$40.3M
Net Cash	$295.7M
Net Cash By Market Cap	$54.89
Net Cash Growth	99.47%
Net Debt Equity	$-1.04
Tangible Book Value	$284M
Tangible Book Value Per Share	$2.18
WACC	5.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	29.56
Net Working Capital	$-7.9M
Quick ratio	29.43
Working Capital	$323.4M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.98%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.43%
200-day SMA	3.79
3Y total return	-11.78%
50-day SMA	2.88
50-day SMA vs 200-day SMA	50under200
5Y total return	-68.81%
All Time High	237.3
All Time High Change	-98.83%
All Time High Date	2017-05-05
All Time Low	1.51
All Time Low Change	83.44%
All Time Low Date	2019-11-19
ATR	0.14
Beta	0.24
Beta1y	1.68
Beta2y	1.58
Ch YTD	-23.27
High	2.89
High52	6.44
High52 Date	2026-01-23
High52ch	-56.99%
Low	2.76
Low52	2.56
Low52 Date	2026-05-01
Low52ch	8.2%
Ma50ch	-3.85%
Premarket Change Percent	-0.32
Premarket Price	$2.83
Premarket Volume	3,355
Price vs 200-day SMA	-26.89%
RSI	41.09
RSI Monthly	41.53
RSI Weekly	40.77
Sharpe ratio	-0.34x
Sortino ratio	-0.4
Total Return	-38.98%
Tr YTD	-23.27
Tr1m	-4.81%
Tr1w	-3.48%
Tr3m	-4.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	7
Analyst Price Target Top	$10.1
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.16
Earnings Revenue Estimate	1,400x
Earnings Revenue Estimate Growth	-72x
Operating Income	$-96.2M
Operating margin	-267,247.2
Price target	$16.89
Price Target Change	$510
Price Target Change Top	$265

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	164,198,533%
Float Percent	84.43%
Net Borrowing	35,000,000
Shares Insiders	0.44%
Shares Institutions	42.89%
Shares Out	194,474,154
Shares Qo Q	23.7%
Shares Yo Y	38.98%
Short Float	29.01%
Short Ratio	10.92
Short Shares	24.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-87.1M
Average Volume	4,019,542.4x
Bv Per Share	2.18
CAPEX	$-32,000
Ch1m	-4.81
Ch1w	-3.48
Ch1y	-35.43
Ch3m	-4.15
Ch3y	-11.78
Ch5y	-68.81
Ch6m	-49.64
Change	-2.46%
Change From Open	-2.81
Close	2.84
Days Gap	0.35
Depreciation Amortization	106,000
Dollar Volume	5,295,010.1
Earnings Date	2026-08-11
Earnings Time	bmo
EBIT	$-96.9M
EBITDA	$-96.8M
EPS	$-0.91
F Score	3
FCF	$-71.7M
FCF EV Yield	-29.49x
FCF Per Share	$-0.37
Financing CF	251,196,000
Fiscal Year End	December
Founded	1,997
Investing CF	-131,062,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2018-09-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-06
Ma150	3.57
Ma150ch	-22.41%
Ma20	2.96
Ma20ch	-6.36%
Net CF	48,497,000
Next Earnings Date	2026-08-11
Open	2.85
Optionable	Yes
Position In Range	7.75
Post Close	2.77
Postmarket Change Percent	1.81
Postmarket Price	$2.82
Ppne	954,000
Pre Close	2.84
Price Date	2026-07-24
Ptbv Ratio	1.9
Relative Volume	0.48x
Revenue	36,000x
SBC By Revenue	42,886.11x
Share Based Comp	15,439,000
Tr6m	-49.64%
Us State	Maryland
Volume	1,911,556
Z Score	2.35

Altimmune, Inc. (ALT)

Coverage state: Market snapshot only — no published research

Generate the first ALT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ALT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ALT

Frequently asked questions